Aethlon Medical, Inc. (AEMD)

Market Cap	5.81M
Revenue (ttm)	n/a
Net Income (ttm)	-12.21M
Shares Out	13.90M
EPS (ttm)	-4.86
PE Ratio	n/a
Forward PE	0.21
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,076,525
Open	0.450
Previous Close	0.450
Day's Range	0.402 - 0.455
52-Week Range	0.370 - 5.000
Beta	1.61
Analysts	Strong Buy
Price Target	7.00 (+1,575.04%)
Earnings Date	Jun 27, 2024

About AEMD

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device for cancer and life-threatening viral infections and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

• Industry: Medical Devices
• Sector: Healthcare
• CEO: James B. Frakes M.B.A.
• Employees: 14
• Stock Exchange: NASDAQ
• Ticker Symbol: AEMD

Analyst Forecast

According to one analyst, the rating for AEMD stock is "Strong Buy" and the 12-month stock price forecast is $7.0.

Price Target

$7.0

(1,575.04% upside)

Analyst Consensus: Strong Buy